Scars are one of the most ubiquitous skin conditions caused due to injuries, burns, acne, and other skin diseases. Scar treatment aims to improve the appearance of scars by reducing their color, size, or prominence on the skin's surface. The scar treatment market in China comprises medical procedures and products used for therapeutic and cosmetic scar treatment. Some common scar treatment options available in the market include topical creams, gels, silicone sheets and dressings, laser therapy, injectable fillers, and surgery. The growing awareness about aesthetics and rising disposable income levels have driven the uptake of scar treatment products and procedures in China.
The Global China Scar Treatment Market Demand is estimated to be valued at US$ 19.01 Mn in 2024 and is expected to exhibit a CAGR of 1.7% over the forecast period 2024 to 2030.
Key Takeaways:
Key players operating in the China scar treatment market are Medtronic Plc, LivaNova PLC, MAQUET Holding B.V. & Co. KG., Terumo Corporation, Braile Biomedica, and Tianjin Medical. Medtronic Plc offers products such as DermaPic and Excel Derm deep-tissue laser systems for scar revision and rejuvenation. Terumo Corporation provides scar treatment products such as silicone gel sheets and dressings under its brand SecurWound.
The rising cosmetic consciousness among Chinese consumers presents significant growth opportunities for non-invasive scar treatment products and services. Moreover, the increasing medical tourism in China as foreigners seek affordable aesthetic procedures further boosts the scar treatment market potential. Chinese companies are also actively exploring opportunities in global markets through partnerships, acquisitions, and expansion of manufacturing and distribution networks.
Market Drivers:
The growing popularity of laser-based scar treatments in China drives the market. Laser therapies help remove or reduce the appearance of scars with techniques such as fractional ablative laser resurfacing and fractional laser scar revision. The non-invasive nature and effectiveness of laser treatments have increased their demand over other scar treatment options.
Market Restrains:
High treatment costs act as a key restraint for the China scar treatment market. Scar revision surgeries and laser therapies involve significant costs which limit their uptake. Post-surgical complications such as hypertrophic scarring can also discourage consumers from opting for invasive scar treatment methods. The lack of comprehensive insurance coverage for scar treatments in China further adds to the economic barriers.
Segment Analysis
The China scar treatment market is dominated by topical scar products such as gels, creams, and ointments. These products are known to be effective in helping reduce the appearance of scars from conditions such as acne, wounds and burns. Amongst these, silicone gel based scar treatments account for over 40% share owing to scientific evidence backing its efficacy in remodeling scar tissue. Laser therapy devices are another fast growing segment and are gaining widespread popularity for treating old and stubborn scars. Increased aesthetic consciousness and willingness to spend on scar diminishing treatments have propelled the demand for laser resurfacing procedures in major Chinese cities.
Global Analysis
The Asia Pacific region holds the highest share in the global scar treatment market driven by China. Rapid economic development, higher discretionary spending on aesthetic procedures and growing medical tourism are some key factors fueling market growth in China. Cities like Beijing, Shanghai and Shenzhen are emerging as hotspots for scar removal therapies. North America is another lucrative region owing to aggressive marketing by US based medical device companies and availability of advanced scar treatment solutions. However, regulations governing aesthetic products are comparatively stricter in North America.
Get more insights on this topic: China Scar Treatment Market
Comments
0 comment